clorazepate dipotassium has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies
Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (enkephalin, ala(2)-mephe(4)-gly(5)-) | Trials (enkephalin, ala(2)-mephe(4)-gly(5)-) | Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-) |
---|---|---|---|---|---|
325 | 90 | 11 | 2,727 | 1 | 374 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barré, L; Coquerel, A; Debruyne, D; Lelong-Boulouard, V; Poisnel, G; Quentin, T | 1 |
1 other study(ies) available for clorazepate dipotassium and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain.
Topics: Animals; Binding Sites; Brain; Buprenorphine; Clorazepate Dipotassium; Drug Administration Schedule; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GABA Modulators; Male; Narcotics; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Tissue Distribution; Tritium | 2005 |